Literature DB >> 17119197

Causal relationship between non-Hodgkin's lymphoma and exposure to benzene and benzene-containing solvents.

Myron A Mehlman1.   

Abstract

Non-Hodgkin's lymphoma (NHL) is a malignant neoplasm of the lymphatic system made up of mainly B cell lymphocytes. A large number of studies have shown significant associations between NHL and benzene or benzene-containing solvents and products. This article summarizes studies detailing these associations and indicates those that are significant. Based on an analysis of the literature and the weight of evidence from numerous studies, it is reasonable to conclude that exposure to benzene or to solvents or products containing benzene is causally related to NHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119197     DOI: 10.1196/annals.1371.004

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

2.  Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS).

Authors:  Shannon M Lynch; Rajeev Mahajan; Laura E Beane Freeman; Jane A Hoppin; Michael C R Alavanja
Journal:  Environ Res       Date:  2009-07-16       Impact factor: 6.498

Review 3.  Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

4.  Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.

Authors:  Nilesh W Gaikwad; Li Yang; Dennis D Weisenburger; Julie Vose; Cheryl Beseler; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.